Burning Rock Biotech (BNR) Revenue & Revenue Breakdown
Burning Rock Biotech Revenue Highlights
Latest Revenue (Y)
$537.43M
Latest Revenue (Q)
$125.62M
Main Segment (Y)
Service
Main Geography (Y)
CHINA
Burning Rock Biotech Revenue by Period
Burning Rock Biotech Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $537.43M | -4.58% |
| 2022-12-31 | $563.24M | 10.90% |
| 2021-12-31 | $507.86M | 18.13% |
| 2020-12-31 | $429.90M | 12.64% |
| 2019-12-31 | $381.68M | 82.74% |
| 2018-12-31 | $208.87M | 87.89% |
| 2017-12-31 | $111.17M | - |
Burning Rock Biotech generated $537.43M in revenue during NA 2023, up -4.58% compared to the previous quarter, and up 257.31% compared to the same period a year ago.
Burning Rock Biotech Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $125.62M | 3.75% |
| 2023-12-31 | $121.08M | -5.08% |
| 2023-09-30 | $127.57M | -12.79% |
| 2023-06-30 | $146.27M | 2.63% |
| 2023-03-31 | $142.52M | 0.20% |
| 2022-12-31 | $142.24M | -8.02% |
| 2022-09-30 | $154.63M | 18.18% |
| 2022-06-30 | $130.85M | -3.45% |
| 2022-03-31 | $135.52M | -8.02% |
| 2021-12-31 | $147.34M | 16.37% |
| 2021-09-30 | $126.61M | -0.52% |
| 2021-06-30 | $127.28M | 19.37% |
| 2021-03-31 | $106.62M | -19.05% |
| 2020-12-31 | $131.72M | 6.33% |
| 2020-09-30 | $123.88M | 15.81% |
| 2020-06-30 | $106.97M | 58.88% |
| 2020-03-31 | $67.33M | -24.07% |
| 2019-12-31 | $88.67M | -14.51% |
| 2019-09-30 | $103.72M | 22.30% |
| 2019-06-30 | $84.81M | -18.81% |
| 2019-03-31 | $104.47M | - |
Burning Rock Biotech generated $125.62M in revenue during Q1 2024, up 3.75% compared to the previous quarter, and up 88.32% compared to the same period a year ago.
Burning Rock Biotech Revenue Breakdown
Burning Rock Biotech Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|
| Product | $192.41M | $234.99M | $165.40M | $118.72M |
| Service | $345.03M | $511.45M | $342.46M | $311.18M |
Burning Rock Biotech's latest annual revenue breakdown by segment (product or service), as of Dec 23: Service (64.20%), and Product (35.80%).
Quarterly Revenue by Product
| Product/Service | Dec 22 | Jun 22 |
|---|---|---|
| Service | $205.97M | $185.58M |
| Product | $90.90M | $80.79M |
Burning Rock Biotech's latest quarterly revenue breakdown by segment (product or service), as of Dec 22: Service (69.38%), and Product (30.62%).
Burning Rock Biotech Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 |
|---|---|---|
| UNITED STATES | $2.51M | $9.93M |
| CHINA | $534.93M | $553.30M |
Burning Rock Biotech's latest annual revenue breakdown by geography, as of Dec 23: CHINA (99.53%), and UNITED STATES (0.47%).
Quarterly Revenue by Country
| Country | Jun 22 |
|---|---|
| Service | $185.58M |
| Product | $80.79M |
Burning Rock Biotech's latest quarterly revenue breakdown by geography, as of Jun 22: Service (69.67%), and Product (30.33%).
Burning Rock Biotech Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| QGEN | Qiagen | $1.97B | $458.80M |
| SHC | Sotera Health Company | $1.05B | $276.59M |
| NEOG | Neogen | $924.22M | $228.81M |
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| CDNA | CareDx | $280.32M | $92.27M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| FONR | FONAR | $98.65M | $25.72M |
| PSNL | Personalis | $73.48M | $19.52M |
| STIM | Neuronetics | $71.35M | $16.45M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| SERA | Sera Prognostics | $306.00K | - |
BNR Revenue FAQ
What is Burning Rock Biotech’s yearly revenue?
Burning Rock Biotech's yearly revenue for 2023 was $537.44M, representing a decrease of -4.58% compared to 2022. The company's yearly revenue for 2022 was $563.24M, representing an increase of 10.90% compared to 2021. BNR's yearly revenue for 2021 was $507.86M, representing an increase of 18.13% compared to 2020.
What is Burning Rock Biotech’s quarterly revenue?
Burning Rock Biotech's quarterly revenue for Q1 2024 was $125.62M, a 3.75% increase from the previous quarter (Q4 2023), and a -11.85% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $121.08M, a -5.08% decrease from the previous quarter (Q3 2023), and a -14.87% decrease year-over-year (Q4 2022). BNR's quarterly revenue for Q3 2023 was $127.57M, a -12.79% decrease from the previous quarter (Q2 2023), and a -17.50% decrease year-over-year (Q3 2022).
What is Burning Rock Biotech’s revenue growth rate?
Burning Rock Biotech's revenue growth rate for the last 3 years (2021-2023) was 5.82%, and for the last 5 years (2019-2023) was 40.81%.
What are Burning Rock Biotech’s revenue streams?
Burning Rock Biotech's revenue streams in c 23 are Product, and Service. Product generated $192.4M in revenue, accounting 35.80% of the company's total revenue, down -18.12% year-over-year. Service generated $345.03M in revenue, accounting 64.20% of the company's total revenue, down -32.54% year-over-year.
What is Burning Rock Biotech’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Burning Rock Biotech was Service. This segment made a revenue of $345.03M, representing 64.20% of the company's total revenue.